Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 09/27 10:00:03 pm
8.07 USD   +0.37%
09/27 RITE AID : Expands Naloxone Dispensing Program in Four Additional St..
09/27 RITE AID : Flu shot clinic in North Tonawanda
09/23DJRITE AID : Business Watch -- WSJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
09/27 RITE AID : Expands Naloxone Dispensing Program in Four Additional States
09/27 RITE AID : Flu shot clinic in North Tonawanda
09/26 RITE AID CORPORATION : Post Earnings Coverage as Rite Aid Q2 Topline Registers G..
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/22 RITE AID CORP : Results of Operations and Financial Condition, Financial Stateme..
09/22 RITE AID : 2Q profit drops on higher costs, revenue rises
09/22 RITE AID : Reports Fiscal 2017 Second Quarter Results
09/21 RITE AID : Dartmouth bits & pieces
09/19 Nabisco New To Top Ten
More news
Sector news : Retail - Drugs without Grocery
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/09DJWALGREENS BOOTS ALLIANCE : To Divest Additional Stores -- WSJ
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
09/25 Insights From Rite Aid's 2nd Quarter
09/23 RITE-AID : We Just Don't Know
09/23 WALL STREET BREAKFAST : OPEC's New Push For Output Freeze Deal
09/22 Valeant Coming Apart
09/22 More on Rite Aid's Q2
Advertisement
Financials ($)
Sales 2017 32 643 M
EBIT 2017 680 M
Net income 2017 147 M
Debt 2017 6 848 M
Yield 2017 -
P/E ratio 2017 55,99
P/E ratio 2018 35,81
EV / Sales 2017 0,47x
EV / Sales 2018 0,44x
Capitalization 8 434 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 8,83 $
Spread / Average Target 9,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION2.93%8 434
RAIA DROGASIL SA89.26%6 814
AIN HOLDINGS INC22.47%2 118
ORIOLA KD OYJ-5.32%835
AUSTRALIAN PHARMACEUTI..-1.55%712
ADCOCK INGRAM HOLDINGS..-7.75%594
More Results